KIP and TISTR Partner to Redefine Biotech Research with AI Precision

Singapore, Singapore, 22nd November 2024, Chainwire

By Chainwire

4 min read

Singapore, Singapore, November 22nd, 2024, Chainwire

Kipley.ai, an AI deployment solutions provider under the KIP Group, has signed a Memorandum of Understanding (MOU) with the Thailand Institute of Scientific and Technological Research (TISTR), Thailand’s largest government research institute operating directly under Thailand’s Ministry of Higher Education, Science, Research and Innovation.

Together, they aim to deploy cutting-edge artificial intelligence (AI) into biotech research, with a focus on identifying and analyzing stem cell samples with unprecedented accuracy and scale to speed up production.

Advancing Medical Research with AI and Decentralized Innovation

Kipley.ai’s solution suite, built on KIP Protocol, exemplifies the KIP Group’s focus on swift and robust implementation of advanced AI into practical applications. 

Co-founded by AI PhDs and tech veterans, Kipley’s leadership and team bring deep expertise in delivering innovative solutions to the public and private sectors. With clients including more than 200 universities around the world, governments, NGOs, data-rich think-tanks, venture capital funds, KIP Group companies have established battle-tested capabilities across diverse industries, positioning it as an ideal partner for advancing research.

Enhancing Stem Cell Analysis with AI Accuracy and Efficiency

This strategic collaboration between Kipley and TISTR brings AI-powered tools to streamline the selection and analysis of stem cell samples. By automating labor-intensive processes using AI, researchers can analyze large datasets with unprecedented accuracy and speed, driving breakthroughs in regenerative medicine. The primary compute provider for this deployment will be IO.net. 

TISTR’s leadership in life sciences and engineering, coupled with Kipley’s advanced technologies, ensures that stem cell samples meet the highest standards of safety and efficacy. These efforts unlock new possibilities for therapies, including the treatment of untreatable diseases and the regeneration of tissues, while adhering to rigorous ethical standards.

A Cross-Border Partnership to Shape Global Scientific Progress

As one of Thailand’s largest government research institutes, TISTR plays a vital role in advancing applied research on a national and international scale. Its partnership with Kipley highlights the immense potential of cross-border collaboration in addressing pressing global challenges.

By blending expertise and technology, this collaboration serves as a model for how public institutions and private enterprises can work together to advance critical scientific research. Their shared focus on innovation and practical outcomes paves the way for breakthroughs in healthcare that have the potential to benefit millions of patients worldwide.

Julian Peh, Co-Founder and CEO of KIP Group, highlighted the partnership’s significance: "We are honored to be working with TISTR, one of the largest scientific research institutes in Thailand. We have been working on, and improving our core AI deployment framework since 2022 and TISTR’s trust in us is a valuable endorsement for the robustness and versatility of our technology. We look forward to deploying our tech to assist TISTR in the important areas of work they spearhead in Thailand."

Dr. Jennifer Dodgson, Co-Founder and Chief AI Officer of Kipley, added: "This partnership allows us to refine how AI analyzes stem cell samples, elevating both the speed and precision of this critical process. Combining Kipley’s AI capabilities with TISTR’s depth in research enables a level of rigor and scalability that positions stem cell science for breakthroughs in both therapies and understanding."

About TISTR

The Thailand Institute of Scientific and Technological Research (TISTR), established in 1963, drives national development through science, technology, and innovation. Operating under the Ministry of Higher Education, Science, Research and Innovation, TISTR focuses on biodiversity, technology transfer, and industrial services to support SMEs, enhance competitiveness, and promote sustainable economic, social, and environmental growth.

About Kipley

Kipley.ai, part of the KIP Group, is built on KIP Protocol and serves as a Web2.5 gateway linking AI models, apps, and decentralized knowledge assets. Kipley combines an intuitive Web2 interface with Web3 security, allowing users to create, monetize, and manage knowledge assets while selecting from multiple AI models in a dynamic marketplace. Kipley’s clients include TISTR, Animoca Ventures, Anomaly, and leading academics from top universities.

About KIP Group

KIP Group drives innovation in AI by developing tools and solutions that enable the creation, management, and monetization of knowledge assets. With a focus on deploying AI solutions rapidly and cost-effectively, KIP Group’s companies provide practical AI solutions for sectors such as education, entertainment, biotechnology and trading. 

With KIP Protocol being a leading decentralized AI deployment and monetisation framework, KIP is also a leading player in DeAI, serving numerous large blockchain and digital asset companies, with a plan to make it accessible and available to all AI developers working in Web3.  

With a client base of leading organizations in both public and private sectors, KIP Group’s core products KIP Protocol and Kipley.ai translates advanced AI technologies into real-world applications, accelerating breakthroughs and driving progress across critical industries.

Contact

Alisa Jiang
press@kip.pro

Get crypto news straight to your inbox--

sign up for the Decrypt Daily below. (It’s free).

Recommended News